Elbasha, Karim https://orcid.org/0000-0002-4763-4874
Kaur, Jatinderjit
Abdelghani, Mohammad
Landt, Martin
Alotaibi, Sultan
Abdelaziz, Ahmed
Abdel-Wahab, Mohamed
Toelg, Ralph
Geist, Volker
Richardt, Gert
Allali, Abdelhakim
Funding for this research was provided by:
Medtronic
Article History
Received: 27 August 2023
Accepted: 16 April 2024
First Online: 12 May 2024
Declarations
:
: Prof. Gert Richardt has received institutional research grants from Biotronik and Medtronic. Dr. Abdelhakim Allali is consultant and proctor for Boston Scientific and consultant for Shockwave Medical. Karim Elbasha, Jatinderjit Kaur, Mohammad Abdelghani, Martin Landt, Sultan Alotaibi, Ahmed Abdelaziz, Mohamed Abdel-Wahab, Ralph Toelg, and Volker Geist have nothing to disclose. Prof. Gert Richardt has a new affiliation to the Center for Cardiovascular and Diabetes Medicine, Asklepios Clinic Bad Oldesloe, Bad Oldesloe, Germany. Dr Ralph Toelg has two new affiliations to the medical Faculty of the Christian-Albrechts-University of Kiel, Kiel, Germany, and to the Center for Cardiovascular and Diabetes Medicine, Asklepios Clinic Bad Oldesloe, Bad Oldesloe, Germany. Gert Richardt is an Editorial Board member of Cardiology and Therapy. Gert Richardt was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: Data of this work were derived from a prospective registry (Post-TAVI registry: NCT03192774) approved by the local ethics committee (Ärztekammer Schleswig–Holstein) and conforming to the Declaration of Helsinki. All patients included in this study have provided a written consent for participation in the local prospective TAVI registry and for a systematic follow-up.